All News & Events
Crystalvue’s Automatic Non-Mydriatic Fundus Cameras, both NFC-700 and NFC-600, have been listed as one of the applicable devices for Acer VeriSee DR.
Crystalvue was awarded Gold Award by Taiwan Bio Industry Organization for the company's outstanding performance, growth strategies and technological innovation.
FDA has cleared Crystalvue Automated Portable Retinal Camera for sale in the United States.
With smart and patient-friendly feature design, Crystalvue NFC-700 was selected as Taiwan Excellence Product for 2020.
Crystalvue goes public through IPO on Taipei Exchange (6527-TW). The price went from $58.8 to $83.1 per share on the first day of IPO.
Industrial Technology Research Institute combines Crystalvue NFC-700 and diagnose software into a self-serving retinal camera, aiming to provide healthcare for remote areas.
Crystalvue's retinal cameras have taken up to 7% of the world’s market share. The next goal for Crystalvue is to expand to 20% in 3-5 years.
'Taipei Biotech Award' is known as 'Biotech Oscar.' NFC-700 is the winner of Go-Globe Special Mention Award of Taipei Biotech Award, 2019
ITRI invites leading manufacturers, academia, and doctors to jointly establish 'Taiwan Vision and Ophthalmic Care Platform', aiming to accelerate commercialization through industry linkage.
Google launches India program to screen diabetics for eye conditions that can cause blindness. Crystalvue and Verily are developing technologies to screen for diabetic retinopathy and diabetic macular edema.
Airdoc, the leader in artificial intelligence field, joined forces in the optical industry with Nova Vision, Visionix, Crystalvue, and Optics Brigde.
Crystalvue's products have been sold to more than 30 countries. With professional teams specializing in R&D, supply chain and quality control, Crystalvue provides high quality and highly competitive products.